Sienna Biopharmaceuticals, Inc., filed a notice for the selection of Successful Bidder in the US Bankruptcy Court for the sale of substantially all its assets on December 5, 2019. As a result of the auction conducted on December 5, 2019, Sebacia, Inc. has been selected as the winning bidder for the sale of substantially all its assets. As per the agreement dated December 5, 2019, seeks the Court’s approval for the sale of substantially all its assets to Sebacia, Inc., for a purchase price of $1.70 million in cash. Under the terms of the asset purchase agreement, the buyer shall make money deposit of $0.05 million upon the execution of the agreement. The buyer is represented by David Wood & Matthew Grimshaw of Marshack Hays LLP as its legal advisors.